Metformin, ivermectin, and fluvoxamine do not prevent severe SARS-CoV-2 infection
1. Metformin, ivermectin, and fluvoxamine do not prevent hypoxemia, emergency department visits, hospitalization, or death in coronavirus disease 2019 (COVID-19) ...
Tag: metformin
#VisualAbstract: Metformin does not improve survival in patients with high-risk, nonmetastatic breast cancer
Click to read this study in JAMA.
Sodium-glucose cotransporter 2 inhibitors reduce heart failure hospitalization in type 2 diabetes patients
1. In patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT-2i) use was associated with reduced risk of composite ...
![Metformin treats Fragile X syndrome symptoms in mice [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2017/07/Metformin_500mg_Tablets-350x250.jpg)
Metformin may improve survival for advanced lung adenocarcinoma patients with higher BMI and taking EGFR-TKI therapy
1. The overall progression-free survival (PFS) was 10.54 years. 2. Patients with body mass weight (BMI) ≥ 24 derived greater ...
Metformin does not improve the progression-free survival of stage IIIA or IIIB locally advanced non-small cell lung cancer patients compared to chemoradiation alone
1. Metformin, in addition to standard chemoradiation therapy, did not improve the progression-free survival, overall survival, local-regional recurrence, or distant ...
#VisualAbstract: Metformin use is associated with a decreased risk of basal cell carcinoma
Click to read the study in the Journal of the American Academy of Dermatology.
Sodium-glucose cotransporter 2 inhibitors associated with reduced mortality compared with sulfonylureas in patients with type 2 diabetes
1. In patients with type 2 diabetes, use of sodium-glucose cotransporter 2 inhibitors was associated with reduced risk of all-cause ...
#VisualAbstract: Metformin for survivors of pediatric brain tumors
1. Metformin was found to be safe and tolerable in survivors of pediatric brain tumors. 2. Metformin was associated with ...
Quick Take: Glycemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY)
1. Early combination therapy with vildagliptin and metformin is associated with improved glycemic durability in the setting of newly diagnosed ...
2 Minute Medicine Rewind September 23, 2019
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, ...
